Intermediate Pituitary Cells, also known as gonadotrophs, constitute a crucial subset of cells in the anterior pituitary gland, a master endocrine organ. These cells play a pivotal role in regulating reproductive functions by secreting gonadotropins—luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH act on the gonads (testes in males and ovaries in females), influencing gamete production and steroid hormone release. Unlike other pituitary cell types, intermediate cells exhibit a unique mix of characteristics, expressing both folliculo-stellate and endocrine cell markers. The secretion of gonadotropins is tightly regulated by the hypothalamus through the release of gonadotropin-releasing hormone (GnRH). In males, LH stimulates the production of testosterone, crucial for spermatogenesis, while FSH supports the maturation of sperm. In females, FSH prompts follicular development in the ovaries, while LH triggers ovulation and promotes the formation of the corpus luteum. Dysfunction in intermediate pituitary cells can lead to reproductive disorders, impacting fertility and hormonal balance. Understanding the intricate regulation and functions of these cells is essential for comprehending reproductive physiology and developing interventions for conditions related to hormonal imbalances in both men and women.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States